** Shares of Sihuan Pharmaceutical Holdings Group Ltd 0460.HK fall 3.4% to HK$0.56, extending losses for a second session
** Stock posts its biggest intraday pct drop since Jan 22
** Sihuan expects to record revenue of not less than 1.80 bln yuan ($248.25 mln) and a net loss of not more than 600 mln yuan for 2024, as generic drug business declines amid centralized procurement policy in the mainland and high R&D expenses
** This compares with a revenue of 1.86 bln yuan and a net loss of 54 mln yuan in 2023
** Hang Seng Commerce & Industry Index .HSNC rises 1.7%, healthcare index .HSCIH gains 0.5% and Hang Seng Index .HSI adds 1%
** Stock climbed 1.5% last year
($1 = 7.2507 Chinese yuan)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.